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GPR55 was recently found to be a novel cannabinoid
receptor and a member of the G protein-coupled receptor
(GPCR) subfamily A. GPR55 is activated by different can-
nabinoid ligands as well as by the lipid ligand lysophos-
phatidylinositol (LPI). Generally, the activity of GPCRs is
coordinated by receptor signaling, receptor desensitiza-
tion and receptor resensitization. The latter two mecha-
nisms are typically associated with the sorting of the
GPCRs between degradation or recycling pathways and
are highly regulated. Several sorting proteins have recently
been identified, for example the G protein-coupled recep-
tor-associated sorting protein-1 (GASP-1). GASP-1 was
originally found to target delta opioid receptors (DORs)
to lysosomes and hence a degradative pathway. This study
shows that GPR55 can internalize after ligand activation
and is subsequently targeted to intracellular vesicles of the
lysosomal compartments. This result and the close simi-
larity of GPR55 to the cannabinoid receptor CB1 – which
is targeted to lysosomes via the GASP-1 protein – sug-
gested that GASP may be involved in targeting GPR55 to
lysosomes. In fact, here we show that the C-terminus of
GPR55 binds GASP-1, cGASP-1 (the C-terminal part of
GASP-1) and GASP-2 (the closest homologue to GASP-1)
in vitro. Both GASP-1 and cGASP-1 show a high affinity to
the C-terminus of GPR55 in vitro, with a ~2-fold higher
affinity for GASP-1 when compared to the DOR. Interest-
ingly, the GASP-2 isoform has the highest affinity for
GPR55 with ~85% when compared to GASP-1 and
cGASP-1 (~80%). This study provides first evidence that
the novel cannabinoid receptor GPR55 is targeted to lyso-
somes after prolonged agonist stimulation and this mech-
anism is likely regulated by members of the newly
discovered G protein-coupled receptor-associated sorting
proteins, i.e GASP-1 and GASP-2.
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